Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01567930
Title Temsirolimus as Second-line Therapy in HCC
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Tennessee Cancer Institute
Indications

hepatocellular carcinoma

Therapies

Temsirolimus

Age Groups: adult
Covered Countries USA


No variant requirements are available.